Gastric resection, whether partial or total gastrectomy, often results in nutrition-related complications including weight loss, diet intolerances, and micronutrient deficiencies. The physiology of normal and postgastrectomy digestion is the basis for most of the current diet recommendations after gastric surgery. A careful review reveals that there is not sufficient literature to support a standard postgastrectomy diet. Rather, individualized diet manipulation for symptom relief is recommended. This review highlights the physiology behind common postgastrectomy complications, provides guidelines for the medical and nutrition management of these complications, and presents a basic approach to postgastrectomy gastrointestinal symptoms.
Berne RM, Levy MN, Koeppen BM, Stanton BA, eds. Physiology. 5th ed. St. Louis, Mo: Elsevier, 2004.
2.
Nelms M., Sucher K., Long S.Nutrition Therapy and Pathophysiology. Belmont , Calif: Thomson Brooks/ Cole; 2007.
3.
Radigan AEPostgastrectomy: managing the nutrition fall-out. Pract Gastroenterol . 2004;XXVII:63-75.*
4.
Rees Parrish C., Krenitsky J., Willcutts K., Radigan AEGastrointestinal disease. In: Gottschlich M, DeLegge M, Mattox T, Mueller C, Worthington P, Guenter P , eds. The A.S.P.E.N. Nutrition Support Core Curriculum: A Case-Based Approach- The Adult Patient. Silver Spring , Md: American Society for Parenteral and Enteral Nutrition;2007:508-539.
5.
Tovey FI, Godfrey JE, Lewin MRA gastrectomy population: 25-30 years on. Postgrad Med J. 1990;66:450-456.
6.
Bozzetti F., Ravera E., Cozzaglio L., et al. Comparison of nutrition status after total or subtotal gastrectomy . Nutrition. 1990;6:371-375.
7.
Staël von Holstein C., Walther B., Ibrahimbegovic E., Akesson B.Nutrition status after total and partial gastrectomy with Roux-en-Y reconstruction . Br J Surg. 1991;78:1084-1087.
8.
Pedrazzani C. , Marrelli D., Rampone B., et al. Postoperative complications and functional results after subtotal gastrectomy with Billroth II reconstruction for primary gastric cancer. Dig Dis Sci . 2007;52:1757-1763.
9.
Speicher JE, Thirlby RC, Burggraaf J., Kelly C., Levasseur S.Results of completion gastrectomies in 44 patients with postsurgical gastric atony. J Gastrointest Surg. 2009;13:874-880.
Svedlund J. , Sullivan M., Liedman B., Lundell L., Sjodin I.Quality of life after gastrectomy for gastric carcinoma: controlled study of reconstructive procedures. World J Surg. 1997;21:422-433.
12.
Liedman B., Andersson H., Berglund B., et al. Food intake after gastrectomy for gastric carcinoma: the role of a gastric reservoir. Br J Surg. 1996;83:1138-1143.
13.
Dong K., Yu XJ, Li B., Wen EG, Xiong W., Guan QLAdvances in mechanisms of postsurgical gastroparesis syndrome and its diagnosis and treatment. Chin J Dig Dis. 2006;7:76-82.
14.
Soykan I., Sivri B., Sarosiek I., Kiernan B., McCallum RWDemography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43:2398-2404.
15.
Schaap HM, Smout AJ, Akkermans LMMyoelectrical activity of the Billroth II gastric remnant. Gut. 1990;31:984-988.
16.
Le Blanc-Louvry I., Savoye G., Maillot C., Denis P., Ducrotte P.An impaired accommodation of the proximal stomach to a meal is associated with symptoms after distal gastrectomy. Am J Gastroenterol. 2003;98:2642-2647.
17.
Le Blanc-Louvry I, Ducrotte P., Peillon C., Michel P., Chiron A., Denis P.Roux-en-Y limb motility after total or distal gastrectomy in symptomatic and asymptomatic patients. J Am Coll Surg. 2000;190:408-417.
18.
Park MI, Camilleri M.Gastroparesis: clinical update. Am J Gastroenterol . 2006;101:1129-1139.
Rabine JC, Barnett JLManagement of the patient with gastroparesis. J Clin Gastroenterol . 2001;32:11-18.
21.
DiBaise JKNutrition consequences of small intestinal bacterial overgrowth. Pract Gastroenterol. 2008;XXXII:15-28.*
22.
Ukleja A.Dumping syndrome: pathophysiology and treatment. Nutr Clin Pract. 2005;20:517-525.
23.
Quigley EM, Quera R.Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology. 2006; 130(2 suppl 1):S78-90.
24.
Vanderhoof JA, Young RJ, Murray N., Kaufman SSTreatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr. 1998;27:155-160.
25.
Attar A., Flourie B., Rambaud JC, Franchisseur C., Ruszniewski P., Bouhnik Y.Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology . 1999;117:794-797.
26.
Sanders MKBezoars: from mystical charms to medical and nutrition management . Pract Gastroenterol. 2004;XXVIII:37-50.*
27.
Karamanolis G., Tack J.Nutrition and motility disorders . Best Pract Res Clin Gastroenterol. 2006 ;20:485-505.
28.
Abell TL, Camilleri M., Donohoe K., et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol. 2008;36:44-54.
29.
Emerson APFoods high in fiber and phytobezoar formation. J Am Diet Assoc . 1987;87:1675-1677.
30.
Hertz AF IV.The cause and treatment of certain unfavorable after-effects of gastro-enterostomy. Ann Surg. 1913;58:466-472.
31.
Tack J., Arts J., Caenepeel P., De Wulf D., Bisschops R.; Medscape. Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nat Rev Gastroenterol Hepatol. 2009 ;6:583-590.
32.
Mayer EA, Thompson JB, Jehn D., Reedy T., Elashoff J., Meyer JHGastric emptying and sieving of solid food and pancreatic and biliary secretion after solid meals in patients with truncal vagotomy and antrectomy . Gastroenterology. 1982;83(1 pt 2):184-192.
33.
Johnson LP, Sloop RD, Jesseph JE, Harkins HNSerotonin antagonists in experimental and clinical "dumping". Ann Surg. 1962;156:537-549.
34.
Andreasen JJ , Orskov C., Holst JJSecretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy. Digestion . 1994;55:221-228.
35.
Shultz KT, Neelon FA, Nilsen LB, Lebovitz HEMechanism of postgastrectomy hypoglycemia. Arch Intern Med . 1971;128: 240-246.
36.
Naslund E., Bogefors J., Skogar S., et al. GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. Am J Physiol. 1999 ;277(3 pt 2):R910-916.
37.
Schattenmann G., Ebert R., Siewert R., Creutzfeldt W.Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum. Scand J Gastroenterol . 1984 ;19:260-266.
38.
Miholic J., Orskov C., Holst JJ, Kotzerke J., Pichlmayr R.Postprandial release of glucagon-like peptide-1, pancreatic glucagon, and insulin after esophageal resection. Digestion. 1993;54:73-78.
39.
Miholic J., Orskov C., Holst JJ, Kotzerke J., Meyer HJEmptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Dig Dis Sci. 1991;36:1361-1370.
40.
McLoughlin JC, Buchanan KD, Alam MJA glycoside-hydrolase inhibitor in treatment of dumping syndrome. Lancet. 1979;2: 603-605.
41.
Gerard J., Luyckx AS, Lefebvre PJAcarbose in reactive hypoglycemia: a double-blind study. Int J Clin Pharmacol Ther Toxicol. 1984;22:25-31.
42.
Speth PA, Jansen JB, Lamers CBEffect of acarbose, pectin, a combination of acarbose with pectin, and placebo on postprandial reactive hypoglycaemia after gastric surgery. Gut. 1983;24:798-802.
43.
Lyons TJ, McLoughlin JC, Shaw C., Buchanan KDEffect of acarbose on biochemical responses and clinical symptoms in dumping syndrome. Digestion. 1985;31:89-96.
44.
Hasegawa T. , Yoneda M., Nakamura K., et al. Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome. J Gastroenterol Hepatol . 1998;13:1201-1206.
45.
Li-Ling J., Irving M.Therapeutic value of octreotide for patients with severe dumping syndrome--a review of randomised controlled trials. Postgrad Med J. 2001;77:441-442.
46.
Hopman WP, Wolberink RG, Lamers CB, Van Tongeren JHTreatment of the dumping syndrome with the somatostatin analogue SMS 201-995 . Ann Surg. 1988;207:155-159.
47.
Primrose JNOctreotide in the treatment of the dumping syndrome . Digestion. 1990;45(suppl 1):49-58; discussion 58-89.
48.
Geer RJ, Richards WO, O’Dorisio TM, et al. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann Surg. 1990;212:678-687.
49.
Vecht J., Lamers CB, Masclee AALong-term results of octreotide-therapy in severe dumping syndrome . Clin Endocrinol (Oxf). 1999;51:619-624.
50.
Arts J., Caenepeel P., Bisschops R., et al. Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping. Clin Gastroenterol Hepatol. 2009;7:432-437.
51.
Penning C., Vecht J., Masclee AAEfficacy of depot long-acting release octreotide therapy in severe dumping syndrome. Aliment Pharmacol Ther. 2005;22:963-969.
Maes BD, Hiele MI, Geypens BJ, Ghoos YF, Rutgeerts PJGastric emptying of the liquid, solid and oil phase of a meal in normal volunteers and patients with Billroth II gastrojejunostomy. Eur J Clin Invest. 1998;28:197-204.
54.
Harju E., Larmi TKEfficacy of guar gum in preventing the dumping syndrome. JPEN J Parenter Enteral Nutr. 1983;7:470-472.
55.
Hopman WP, Houben PG, Speth PA, Lamers CBGlucomannan prevents postprandial hypoglycaemia in patients with previous gastric surgery. Gut. 1988;29:930-934.
56.
Grant JP, Chapman G., Russell MKMalabsorption associated with surgical procedures and its treatment . Nutr Clin Pract. 1996;11: 43-52.
57.
Sategna-Guidetti C., Bianco L.Malnutrition and malabsorption after total gastrectomy: a pathophysiologic approach. J Clin Gastroenterol . 1989;11:518-524.
58.
Bae JM, Park JW, Yang HK, Kim JPNutrition status of gastric cancer patients after total gastrectomy . World J Surg. 1998;22:254-260; discussion 260-261.
59.
Friess H., Bohm J., Muller MW, et al. Maldigestion after total gastrectomy is associated with pancreatic insufficiency. Am J Gastroenterol. 1996;91:341-347.
60.
Fischermann K., Harly S., Worning H., Zacho A.Pancreatic function and the absorption of fat, iron, vitamin B12, and calcium after total gastrectomy for gastric cancer . Gut. 1967;8:260-266.
61.
Armbrecht U. , Lundell L., Stockbrugger RWThe benefit of pancreatic enzyme substitution after total gastrectomy. Aliment Pharmacol Ther. 1988;2:493-500.
62.
Bragelmann R., Armbrecht U., Rosemeyer D., Schneider B., Zilly W., Stockbrugger RWThe effect of pancreatic enzyme supplementation in patients with steatorrhoea after total gastrectomy. Eur J Gastroenterol Hepatol. 1999;11:231-237.
63.
Griffiths A. , Taylor RHPostgastrectomy pancreatic malabsorption: is there a case for intervention? Eur J Gastroenterol Hepatol . 1999; 11:219-221.
Stanley SLDiagnosis and treatment of vitamin B12 and folic acid deficiency. http://www.uptodate.com/online/content/topic.do?topicKey=red_cell/6632&selectedTitle=1%7E22&source=search_result. Updated 2010. Accessed September 30, 2010.
68.
Pawson R., Mehta A.Review article: the diagnosis and treatment of haematinic deficiency in gastrointestinal disease. Aliment Pharmacol Ther. 1998;12:687-698.
69.
Lizarraga A. , Cuerda C., Junca E., et al. Atrophy of the intestinal villi in a postgastrectomy patient with severe iron deficiency anemia. Nutr Hosp. 2009;24:618-621.
70.
Carlson THLaboratory data in nutrition assessment. In: Mahan LK, Escott-Stump S, eds. Krause’s Food Nutrition and Diet Therapy. 11th ed. Philadelphia, Pa: Elsevier;2004:436-454.
Zittel TT, Zeeb B., Maier GW, et al. High prevalence of bone disorders after gastrectomy. Am J Surg. 1997;174:431-438.
73.
Bisballe S. , Eriksen EF, Melsen F., Mosekilde L., Sorensen OH, Hessov I.Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry . Gut. 1991; 32:1303-1307.
74.
Liedman B., Henningsson A., Mellstrom D., Lundell L.Changes in bone metabolism and body composition after total gastrectomy: results of a longitudinal study. Dig Dis Sci. 2000 ;45: 819-824.
75.
Bernstein CN , Leslie WDThe pathophysiology of bone disease in gastrointestinal disease. Eur J Gastroenterol Hepatol. 2003 ;15: 857-864.
76.
Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-58.
77.
Copland L., Liedman B., Rothenberg E., Bosaeus I.Effects of nutrition support long time after total gastrectomy. Clin Nutr. 2007; 26:605-613.
78.
Farahmand M. , Sheppard BC, Deveney CW, Deveney KE, Crass RALong-term outcome of completion gastrectomy for nonmalignant disease. J Gastrointest Surg. 1997;1:182-187.
79.
Tokunaga M. , Hiki N., Ohyama S., et al. Effects of reconstruction methods on a patient’s quality of life after a proximal gastrectomy: subjective symptoms evaluation using questionnaire survey. Langenbecks Arch Surg. 2009;394:637-641.
80.
Nunobe S., Okaro A., Sasako M., et al. Billroth 1 versus Roux-en-Y reconstructions: a quality-of-life survey at 5 years. Int J Clin Oncol. 2007;12:433-439.
81.
Svedlund J. , Sullivan M., Liedman B., Lundell L.Long term consequences of gastrectomy for patient’s quality of life: the impact of reconstructive techniques. Am J Gastroenterol. 1999;94:438-445.
